Arthur Melms

Expression of the B7-related molecule ICOSL by human glioma cells in vitro and in vivo.

A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape.

High immunogenicity of intracellular myelin oligodendrocyte glycoprotein epitopes.

The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy.

Muscle fibres and cultured muscle cells express the B7.1/2-related inducible co-stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathies.

Human herpesvirus 6 in serum and spinal fluid of patients with multiple sclerosis?

Antigen processing and presentation in human muscle: cathepsin S is critical for MHC class II expression and upregulated in inflammatory myopathies.

The CD28 related molecule ICOS: T cell modulation in the presence and absence of B7.1/2 and regulational expression in multiple sclerosis.

Human muscle cells express a B7-related molecule, B7-H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies.

Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis.

Action of treosulfan in myelin-oligodendrocyte-glycoprotein-induced experimental autoimmune encephalomyelitis and human lymphocytes.

Analysis of autoreactive CD4 T cells in experimental autoimmune encephalomyelitis after primary and secondary challenge using MHC class II tetramers.

Different patterns of nicotinic acetylcholine receptor subunit transcription in human thymus.

Cathepsin G, and not the asparagine-specific endoprotease, controls the processing of myelin basic protein in lysosomes from human B lymphocytes.

A structurally available encephalitogenic epitope of myelin oligodendrocyte glycoprotein specifically induces a diversified pathogenic autoimmune response.

Lack of pathogenicity of immunodominant T and B cell determinants of the nicotinic acetylcholine receptor epsilon-chain.

MHC class II isotype- and allele-specific attenuation of experimental autoimmune encephalomyelitis.

3-hydroxy-3-methylglutaryl-CoA lyase deficiency in an adult with leukoencephalopathy.

Delayed resolution of white matter changes following therapy of B burgdorferi encephalitis.

CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A (CSA) than under other medications--results of a retrospective analysis of 117 cases.

Expression of toll-like receptors by human muscle cells in vitro and in vivo: TLR3 is highly expressed in inflammatory and HIV myopathies, mediates IL-8 release and up-regulation of NKG2D-ligands.

Induction of autoimmunity by expansion of autoreactive CD4+CD62Llow cells in vivo.

Specificity of human cathepsin S determined by processing of peptide substrates and MHC class II-associated invariant chain.

Osteopontin is elevated in Parkinson's disease and its absence leads to reduced neurodegeneration in the MPTP model.

HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation.

Treatment of active secondary progressive multiple sclerosis with treosulfan.

Dendritic cell-regulatory T-cell interactions control self-directed immunity.

Polymorphisms in the cathepsin L2 (CTSL2) gene show association with type 1 diabetes and early-onset myasthenia gravis.

Congestive radiculopathy.

Complementary strategies to elucidate T helper cell epitopes in myasthenia gravis.

Cathepsin G is differentially expressed in primary human antigen-presenting cells.

Cathepsin W expressed exclusively in CD8+ T cells and NK cells, is secreted during target cell killing but is not essential for cytotoxicity in human CTLs.

Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics.

A single-nucleotide polymorphism of the osteopontin gene may contribute to a susceptibility to Lewy body disease.

Differential modulation of CNS-specific effector and regulatory T cells during tolerance induction by recombinant invariant chains in vivo.

The autoimmunity-related polymorphism PTPN22 1858C/T is associated with anti-titin antibody-positive myasthenia gravis.

No differences of butyrylcholinesterase protein activity and allele frequency in Lewy body diseases.

Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients.

The CST3 BB genotype and low cystatin C cerebrospinal fluid levels are associated with dementia in Lewy body disease.

Aquaporin 4 antibody positive central nervous system autoimmunity and multiple sclerosis are characterized by a distinct profile of antibodies to herpes viruses.

CD62L(high) Treg cells with superior immunosuppressive properties accumulate within the CNS during remissions of EAE.

Neprilysin activity in cerebrospinal fluid is associated with dementia and amyloid-β42 levels in Lewy body disease.

Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders.

Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias.

Serum and cerebrospinal fluid uric acid levels in lewy body disorders: associations with disease occurrence and amyloid-β pathway.

Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis.

Confirmation of R132H mutation of isocitrate dehydrogenase 1 as an independent prognostic factor in anaplastic astrocytoma.

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients.

Cathepsin S dominates autoantigen processing in human thymic dendritic cells.

Elevated plasma levels of neuropeptide proenkephalin a predict mortality and functional outcome in ischemic stroke.

Current concepts of the interventional treatment of proximal supraaortic vessel stenosis.

Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.

Serum and cerebrospinal fluid levels of transthyretin in Lewy body disorders with and without dementia.

Recognition performance differentiates between elderly patients in the long term course of secondary progressive multiple sclerosis and amnestic mild cognitive impairment.

Plasma levels of soluble glycoprotein VI (sGPVI) are associated with ischemic stroke.

Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy.

Plasma Exchange Is Effective in a 13-Year-Old Girl with Steroid-Resistant Bilateral Optic Neuritis.

The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes.

Exploring the MHC-peptide matrix of central tolerance in the human thymus.